211 related articles for article (PubMed ID: 19766104)
1. Dietary salt restriction activates mineralocorticoid receptor signaling in volume-overloaded heart failure.
Mori T; Kurumazuka D; Matsumoto C; Shirakawa H; Kimura S; Kitada K; Kobayashi K; Matsuda H; Hayashi T; Kitaura Y; Matsumura Y
Eur J Pharmacol; 2009 Nov; 623(1-3):84-8. PubMed ID: 19766104
[TBL] [Abstract][Full Text] [Related]
2. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
3. Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene.
Nishikimi T; Hagaman JR; Takahashi N; Kim HS; Matsuoka H; Smithies O; Maeda N
Cardiovasc Res; 2005 Apr; 66(1):94-103. PubMed ID: 15769452
[TBL] [Abstract][Full Text] [Related]
4. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
Brilla CG; Schencking M; Scheer C; Rupp H
Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851
[TBL] [Abstract][Full Text] [Related]
5. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
[TBL] [Abstract][Full Text] [Related]
6. Expression of procollagen C-proteinase enhancer-1 in the remodeling rat heart is stimulated by aldosterone.
Kessler-Icekson G; Schlesinger H; Freimann S; Kessler E
Int J Biochem Cell Biol; 2006 Mar; 38(3):358-65. PubMed ID: 16300990
[TBL] [Abstract][Full Text] [Related]
7. Mineralocorticoid receptor antagonist spironolactone prevents pig serum-induced hepatic fibrosis in rats.
Fujisawa G; Muto S; Okada K; Kusano E; Ishibashi S
Transl Res; 2006 Sep; 148(3):149-56. PubMed ID: 16938653
[TBL] [Abstract][Full Text] [Related]
8. Hypertension-induced renal fibrosis and spironolactone response vary by rat strain and mineralocorticoid receptor gene expression.
Cavallari LH; Fashingbauer LA; Camp JR; King ST; Geenen DL
J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):146-53. PubMed ID: 18957385
[TBL] [Abstract][Full Text] [Related]
9. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism.
Brilla CG; Matsubara LS; Weber KT
J Mol Cell Cardiol; 1993 May; 25(5):563-75. PubMed ID: 8377216
[TBL] [Abstract][Full Text] [Related]
10. Effects of salt status and blockade of mineralocorticoid receptors on aldosterone-induced cardiac injury.
Hattori T; Murase T; Sugiura Y; Nagasawa K; Takahashi K; Ohtake M; Ohtake M; Miyachi M; Murohara T; Nagata K
Hypertens Res; 2014 Feb; 37(2):125-33. PubMed ID: 24048492
[TBL] [Abstract][Full Text] [Related]
11. Effect of sodium intake on aldosterone and corticosterone production, the serum sodium concentration and body weight in infant rats during weaning period.
Erdösová R; Kraus M
Physiol Bohemoslov; 1976; 25(1):1-6. PubMed ID: 131329
[TBL] [Abstract][Full Text] [Related]
12. Retinal vasculopathy is reduced by dietary salt restriction: involvement of Glia, ENaCα, and the renin-angiotensin-aldosterone system.
Deliyanti D; Armani R; Casely D; Figgett WA; Agrotis A; Wilkinson-Berka JL
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2033-41. PubMed ID: 25012132
[TBL] [Abstract][Full Text] [Related]
13. Combined effects of low-dose spironolactone and captopril therapy in a rat model of genetic hypertrophic cardiomyopathy.
de Resende MM; Kriegel AJ; Greene AS
J Cardiovasc Pharmacol; 2006 Dec; 48(6):265-73. PubMed ID: 17204904
[TBL] [Abstract][Full Text] [Related]
14. Prevention of cardiac remodeling after myocardial infarction in transgenic rats deficient in brain angiotensinogen.
Lal A; Veinot JP; Ganten D; Leenen FH
J Mol Cell Cardiol; 2005 Sep; 39(3):521-9. PubMed ID: 15950985
[TBL] [Abstract][Full Text] [Related]
15. Effects of hydrochlorothiazide on cardiac remodeling in a rat model of myocardial infarction-induced congestive heart failure.
Luo J; Gao X; Peng L; Sun H; Dai G
Eur J Pharmacol; 2011 Sep; 667(1-3):314-21. PubMed ID: 21703256
[TBL] [Abstract][Full Text] [Related]
16. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
Neves MF; Amiri F; Virdis A; Diep QN; Schiffrin EL;
Can J Physiol Pharmacol; 2005 Nov; 83(11):999-1006. PubMed ID: 16391708
[TBL] [Abstract][Full Text] [Related]
17. Induction of cardiac fibrosis by aldosterone.
Lijnen P; Petrov V
J Mol Cell Cardiol; 2000 Jun; 32(6):865-79. PubMed ID: 10888242
[TBL] [Abstract][Full Text] [Related]
18. Aldosterone increases plasminogen activator inhibitor-1 synthesis in rat cardiomyocytes.
Chun TY; Pratt JH
Mol Cell Endocrinol; 2005 Jul; 239(1-2):55-61. PubMed ID: 15921847
[TBL] [Abstract][Full Text] [Related]
19. Alterations in aldosterone and angiotensin II levels in salt-induced hypertension.
Bayorh MA; Ganafa AA; Emmett N; Socci RR; Eatman D; Fridie IL
Clin Exp Hypertens; 2005 May; 27(4):355-67. PubMed ID: 15921072
[TBL] [Abstract][Full Text] [Related]
20. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
Nagata K; Obata K; Xu J; Ichihara S; Noda A; Kimata H; Kato T; Izawa H; Murohara T; Yokota M
Hypertension; 2006 Apr; 47(4):656-64. PubMed ID: 16505208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
